Amphastar P
AMPHAmphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures and sells inhalation and intranasal products.One of its products is naloxone, an injectable generic drug that treats opioid overdose, and th …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Amphastar P
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/1/2025 | Sell | Petersen, Floyd F. | Director | $28.4 | $14,190 |
| 3/6/2025 | Sell | Petersen, Floyd F. | Director | $28.0 | $27,986 |
| 3/4/2025 | Sell | Peters, William J. | CFO, EVP & TREASURER | $27.5 | $116,515 |
| 12/13/2024 | Sell | Zhou, Rong | SENIOR EVP, PRODUCTION CENTER | $45.2 | $361,840 |
| 12/12/2024 | Sell | Zhou, Rong | SENIOR EVP, PRODUCTION CENTER | $44.4 | $310,975 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)